These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 10862822
1. Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum. Liu W, Wu CF, Liu J, Huang M, Xiao K. Eur J Pharmacol; 2000 Jun 23; 398(3):333-9. PubMed ID: 10862822 [Abstract] [Full Text] [Related]
2. Effects of clozapine, olanzapine and haloperidol on ethanol-induced ascorbic acid release in mouse striatum. Hou Y, Yang JY, Wu CF, Huang M. Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan 23; 29(1):83-9. PubMed ID: 15610949 [Abstract] [Full Text] [Related]
3. Differential effects of clozapine on ethanol-induced ascorbic acid release in mouse and rat striatum. Hou Y, Wu CF, Yang JY, Tu L, Gu PF, Bi XL. Neurosci Lett; 2005 Jan 23; 380(1-2):83-7. PubMed ID: 15854756 [Abstract] [Full Text] [Related]
4. Similar effects of clozapine and olanzapine on ethanol-induced ascorbic acid release in the prefrontal cortex of freely moving mice. Hou Y, Wu CF, Yang JY, Gu PF, Bi XL, Dai F. Pharmazie; 2007 Feb 23; 62(2):158-60. PubMed ID: 17341041 [Abstract] [Full Text] [Related]
5. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism. Brougham LR, Conway PG, Ellis DB. Neuropharmacology; 1991 Oct 23; 30(10):1137-40. PubMed ID: 1684649 [Abstract] [Full Text] [Related]
6. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Oh C, Gardiner TW, Rebec GV. Brain Res; 1989 Feb 20; 480(1-2):184-9. PubMed ID: 2565749 [Abstract] [Full Text] [Related]
7. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM, Connick JH. Eur J Pharmacol; 1998 Dec 04; 362(2-3):127-36. PubMed ID: 9874162 [Abstract] [Full Text] [Related]
14. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K. Br J Pharmacol; 1997 Jun 04; 121(3):515-25. PubMed ID: 9179395 [Abstract] [Full Text] [Related]
15. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G. J Pharmacol Exp Ther; 1998 Sep 04; 286(3):1341-55. PubMed ID: 9732398 [Abstract] [Full Text] [Related]
18. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. Merchant KM, Dobner PR, Dorsa DM. J Neurosci; 1992 Feb 04; 12(2):652-63. PubMed ID: 1531499 [Abstract] [Full Text] [Related]
19. Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Cosi C, Waget A, Rollet K, Tesori V, Newman-Tancredi A. Brain Res; 2005 May 10; 1043(1-2):32-41. PubMed ID: 15862515 [Abstract] [Full Text] [Related]